IO Biotech, Inc. (IOBT) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
IO Biotech, Inc. (IOBT) Bundle
Evaluate IO Biotech, Inc.’s (IOBT) financial outlook with expert precision! This (IOBT) DCF Calculator comes with pre-filled financial data and allows you to easily modify revenue growth, WACC, margins, and other critical assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -.8 | .0 | -67.5 | -69.3 | -91.4 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | 9.9 | 10.1 | .0 | .5 | .2 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -10.7 | -10.1 | -67.5 | -69.9 | -91.7 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 7.8 | 3.4 | 211.5 | 142.6 | 143.2 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1.2 | 1.5 | 2.1 | 1.5 | 1.1 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .2 | .4 | -2.1 | -1.5 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | 1.0 | .5 | 3.9 | 4.0 | 3.9 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | .0 | .0 | -.2 | -.7 | -.3 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 | -0.99964 |
EBITAT | -10.7 | -10.2 | -67.5 | -71.2 | -92.6 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1.3 | -.9 | -62.4 | -71.2 | -93.9 | -2.8 | .0 | .0 | .0 | .0 |
WACC, % | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 |
PV UFCF | ||||||||||
SUM PV UFCF | -2.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -3 | |||||||||
Net Debt | -141 | |||||||||
Equity Value | 138 | |||||||||
Diluted Shares Outstanding, MM | 44 | |||||||||
Equity Value Per Share | 3.17 |
What You Will Receive
- Accurate IOBT Financial Data: Pre-filled with IO Biotech’s historical and projected data for detailed analysis.
- Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch IOBT’s intrinsic value update in real-time as you make adjustments.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: Streamlined layout and straightforward instructions suitable for all skill levels.
Key Features
- Comprehensive Data: IO Biotech’s historical financial reports and projected forecasts.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
- Real-Time Results: Instantly view IO Biotech’s intrinsic value as you modify inputs.
- Intuitive Visual Outputs: Dashboard graphs illustrate valuation results and essential metrics.
- Precision Engineered: A reliable tool designed for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template with IO Biotech’s (IOBT) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including IO Biotech’s (IOBT) intrinsic value.
- Step 5: Make informed investment decisions or create reports using the outputs.
Why Choose IO Biotech, Inc. (IOBT) Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for biotech.
- Flexible Inputs: Modify highlighted cells to explore different investment scenarios.
- In-Depth Analysis: Automatically computes IO Biotech’s intrinsic value and Net Present Value.
- Integrated Data: Historical and projected data provide a strong foundation for analysis.
- Expert-Level Tool: Perfect for financial analysts, biotech investors, and business advisors.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling IO Biotech, Inc. (IOBT) stock.
- Financial Analysts: Enhance valuation processes with comprehensive financial models specific to IO Biotech, Inc. (IOBT).
- Consultants: Provide clients with expert valuation insights related to IO Biotech, Inc. (IOBT) efficiently and accurately.
- Business Owners: Gain insights into how biotech companies like IO Biotech, Inc. (IOBT) are valued to inform your own business strategies.
- Finance Students: Master valuation techniques using real-world data and case studies from IO Biotech, Inc. (IOBT).
What the Template Contains
- Historical Data: Includes IO Biotech's past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate IO Biotech's intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of IO Biotech's financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.